Internal Medicine, Endocrinology, Diabetes, & Metabolism · Kinston, NC
NPI
1982916342
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
701 Doctors Dr Ste D
Kinston, NC, 28501
Phone (252) 559-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$157K
13,057 services
Medicare patients, 2024
318
Average age 71
Drug cost, 2024
$4.2M
6,940 prescriptions
Company payments, 2025
$1,419
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vengamamba Polu was code 99214 (office e&m - established), 608 times for 250 patients. In total Vengamamba Polu billed 13,057 services in 43 codes, and Medicare paid $157K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 608 | 250 | $89.31 | $54K |
| 82962 Clinical Chemistry | Office | 434 | 170 | $3.20 | $1,390 |
| 83036 Blood Count | Office | 412 | 170 | $9.50 | $3,914 |
| 95251 Test - Miscellaneous | Office | 222 | 77 | $26.68 | $5,923 |
| 36415 Venipuncture Blood Collection | Office | 166 | 105 | $8.65 | $1,436 |
| 84439 Clinical Chemistry | Office | 147 | 74 | $8.84 | $1,299 |
| 84443 Clinical Chemistry | Office | 146 | 73 | $16.46 | $2,403 |
| 84480 Clinical Chemistry | Office | 107 | 73 | $13.90 | $1,487 |
| 99204 Office E&M - New | Office | 102 | 102 | $119.44 | $12K |
| 99215 Office E&M - Established | Office | 87 | 51 | $134.58 | $12K |
| 80048 Clinical Chemistry | Office | 52 | 43 | $8.29 | $431 |
| 99442 Telephone Services | Office | 46 | 40 | $70.96 | $3,264 |
| 82306 Clinical Chemistry | Office | 29 | 22 | $29.01 | $841 |
| 99443 Telephone Services | Office | 26 | 21 | $92.39 | $2,402 |
| 82043 Clinical Chemistry | Office | 25 | 22 | $5.47 | $137 |
By year: 2022 $111K for 7,827 services; 2023 $131K for 11,577 services; 2024 $157K for 13,057 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 434 | 170 | $3.20 | $1,390 |
| 83036 Blood Count | 412 | 170 | $9.50 | $3,914 |
| 36415 Venipuncture Blood Collection | 166 | 105 | $8.65 | $1,436 |
| 84439 Clinical Chemistry | 147 | 74 | $8.84 | $1,299 |
| 84443 Clinical Chemistry | 146 | 73 | $16.46 | $2,403 |
| 84480 Clinical Chemistry | 107 | 73 | $13.90 | $1,487 |
| 80048 Clinical Chemistry | 52 | 43 | $8.29 | $431 |
| 82306 Clinical Chemistry | 29 | 22 | $29.01 | $841 |
| 82043 Clinical Chemistry | 25 | 22 | $5.47 | $137 |
| 83970 Clinical Chemistry | 22 | 17 | $40.45 | $890 |
Medicare prescription drug claims, 2024
In 2024, the drug Vengamamba Polu prescribed most often to Medicare patients was Ozempic (Semaglutide), with 468 prescriptions and refills. In total Vengamamba Polu wrote 6,940 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 468 | 622 | 108 | $601K |
| Omnipod Dash Pods (Gen 4) Insulin Pump Cart,cont Inf,bt | 467 | 753 | 101 | $459K |
| Farxiga Dapagliflozin Propanediol | 376 | 497 | 84 | $286K |
| Levothyroxine Sodium Generic | 370 | 651 | 93 | $2,447 |
| Mounjaro Tirzepatide | 346 | 387 | 67 | $415K |
| Jardiance Empagliflozin | 342 | 521 | 78 | $304K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 325 | 562 | 86 | $248K |
| Metformin Hcl Generic | 310 | 618 | 83 | $1,874 |
| Glipizide Er Glipizide | 292 | 492 | 72 | $2,766 |
| Tradjenta Linagliptin | 242 | 287 | 51 | $145K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 185 | 368 | 67 | $17K |
| Trulicity Dulaglutide | 180 | 214 | 48 | $207K |
| Rybelsus Semaglutide | 149 | 248 | 42 | $235K |
| Metformin Hcl Er Metformin Hcl | 141 | 271 | 44 | $808 |
| Lyumjev Insulin Lispro-Aabc | 135 | 149 | 19 | $117K |
Brand drugs: 4,522 claims; generic drugs: 1,659 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vengamamba Polu $1,419 ($1,419 in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $303.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 18 | $303 |
| Corcept Therapeutics CORT | 13 | $186 |
| Lilly USA, LLC LLY | 9 | $153 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $91.46 |
| Abbott Laboratories ABT | 4 | $91.43 |
| Radius Health, Inc. | 3 | $56.04 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $50.26 |
| Sequel Med Tech, LLC | 2 | $43.61 |
| Kyowa Kirin, Inc. 4151.T | 2 | $41.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.